Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kenneth C. Frazier files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Column Group IV GP, LP - $39.15M in EIKN purchases and sales in the last 12 months
- Josh Wolfe - $5.00M in EIKN purchases and sales in the last 12 months
- Lux Venture Partners V, LLC - $5.00M in EIKN purchases and sales in the last 12 months
- Foresite Capital Management IV, LLC - $1000K in EIKN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kenneth C. Frazier?
Kenneth C. Frazier is a corporate insider of Eikon Therapeutics, Inc. (EIKN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kenneth C. Frazier last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 2 filings going back to 2026.
Has Kenneth C. Frazier been buying or selling stock?
Recorded transactions: 1 open-market purchase ($2.00M) and 0 open-market sales across all tracked filings.
